Related Experiment Video

Updated: May 9, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma

F Yu1, W Gao2, T Yokochi3

  • 11] Division of Biochemistry and Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, Chiba, Japan [2] Department of Molecular Biology and Oncology, Chiba University Graduate School of Medicine, Chiba, Japan [3] Department of Thoracic Surgery, Forth Hospital of Hebei Medical University, Hebei, PRC.

Oncogene
|July 16, 2013
PubMed

Insights

High RUNX3 expression correlates with better outcomes in neuroblastoma, potentially overcoming MYCN

Area of Science:

  • Neuro-oncology
  • Cancer biology
  • Molecular genetics

Background:

  • RUNX3 (runt-related transcription factor 3) is implicated in neurogenesis and acts as a tumor suppressor in several cancers.
  • The role of RUNX3 in neuroblastoma, a pediatric cancer, is not well understood.

Purpose of the Study:

  • To investigate the biological role and prognostic significance of RUNX3 in neuroblastoma.
  • To elucidate the molecular mechanisms underlying RUNX3's function in neuroblastoma, particularly in relation to MYCN.

Main Methods:

  • Analysis of RUNX3 expression levels in neuroblastoma patient cohorts.
  • Array-based analysis to identify genetic alterations associated with RUNX3 downregulation.
  • In vitro studies involving exogenous RUNX3 expression in neuroblastoma cell lines.
  • Investigation of the interaction between RUNX3 and MYCN protein stability.

Main Results:

  • High RUNX3 expression is associated with favorable patient outcomes, while low expression indicates poor prognosis.
  • Allelic loss at chromosome 1p36 contributes to RUNX3 downregulation in advanced neuroblastomas.
  • RUNX3 overexpression inhibits neuroblastoma cell proliferation and migration.
  • RUNX3 reduces MYCN protein stability, suggesting a mechanism to counteract MYCN's oncogenic activity.

Conclusions:

  • RUNX3 functions as a tumor suppressor in neuroblastoma.
  • RUNX3's favorable prognostic role may stem from its ability to inhibit MYCN activity.
  • RUNX3 represents a potential therapeutic target for neuroblastoma treatment.

More Related Videos

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...